Optimizing molecular weight of octyl chitosan as drug carrier for improving tumor therapeutic efficacy

Macromolecular drug carriers have attracted much attention taking advantage of passive tumor targeting property and excellent biocompatibility. For many biomedical applications, however, the effectiveness of the carriers is insufficient, which complicate further development into clinical use. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Min, Ma, Yi, Wang, Zhaohui, Han, Zhihao, Gao, Weidong, Gu, Yueqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609998/
https://www.ncbi.nlm.nih.gov/pubmed/28969066
http://dx.doi.org/10.18632/oncotarget.19452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609998/
https://www.ncbi.nlm.nih.gov/pubmed/28969066
http://dx.doi.org/10.18632/oncotarget.19452

Ejemplares similares